Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
Abstract
Standard chemotherapy for newly diagnosed ovarian cancer is a platinum-taxane combination. The Gynecologic Oncology Group conducted a randomized, phase 3 trial that compared intravenous paclitaxel plus cisplatin with intravenous paclitaxel plus intraperitoneal cisplatin and paclitaxel in patients with stage III ovarian cancer.We randomly assigned patients with stage III ovarian carcinoma or primary peritoneal carcinoma with no residual mass...
Paper Details
Title
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
Published Date
Jan 5, 2006
Volume
354
Issue
1
Pages
34 - 43
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History